(Bloomberg) — A week after Axa SA ousted Peter Kraus from its AllianceBernstein Holding LP unit, the French insurer is taking steps to reduce its financial investment in the money manager to raise cash for insurance deals.
Axa, Europe’s second-largest insurer, on Wednesday announced a plan to list a minority stake in its U.S. businesses, including its U.S. Life Savings unit and its 64 percent stake in AllianceBernstein. Proceeds from the initial public offering, scheduled for the first half of next year, will be used to fund acquisitions worldwide in areas Axa has earmarked for growth, such as health, protection and commercial property and casualty lines.
The U.S. listing “is a big surprise,” said Daniel Bischof, a Zurich-based analyst at Baader Helvea AG. “With the recent personnel changes, some change was expected at AllianceBernstein.”
Axa Chief Executive Officer Thomas Buberl, who took over last year, told analysts on a conference call that the IPO was separate from the management shakeup at AllianceBernstein, and was intended to accelerate the firm’s growth strategy. Axa has owned a majority in the predecessor of Alliance Bernstein since 1991. Assets under management at the business have dropped to $498 billion from more than $800 billion in 2007 as investors flee active asset managers for low-cost index funds.
AllianceBernstein CEO Kraus, who was removed last week along with nine directors, said last year that active investment managers may need to shrink by as much as a third if they want to beat industry benchmarks again.
For more on consolidation in asset management, click here
Axa is not planning to buy out minority shareholders in AllianceBernstein, Buberl said on a conference call on Wednesday. The new U.S. unit should help realize “synergies” between the life insurance business, the asset manager and the distribution network, he said. Chief Financial Officer Gerald Harlin said the U.S. insurance unit could provide “seed money” to AllianceBernstein to develop “sophisticated, attractive” products in a low-rate environment.
While Buberl called the U.S. an important market for Axa, he didn’t rule out reducing the insurer’s stake in the U.S.-listed business in the future, saying the company will be “opportunistic.”
Axa rose as much as 2.6 percent before reversing gains to trade 0.7 percent lower at 1:21 p.m. in Paris trading. The stock is up 1.5 percent this year. AllianceBernstein, which trades in New York, lost 10 percent through Tuesday.
Buberl aims to preserve the firm’s profitability through cost cuts, new-technology investments and tapping growing demand for health insurance. The company on Wednesday confirmed key 2020 profit targets, including an adjusted return on equity of 12 percent to 14 percent, and average underlying earnings per share growth of 3 percent to 7 percent a year.
To help meet those goals, Axa has a budget of about 1 billion euros a year for acquisitions. Buberl said the company will be “very active” in pursuing any potential targets, in markets including Thailand, Indonesia, China. The IPO will increase Axa’s financial flexibility to fund larger investments as well, he said. Should the company find no suitable targets, Axa said could return cash to shareholders instead.
“We would like to focus on deals of the magnitude” between 1 billion euros and 3 billion euros, Buberl said. “We are not ruling out for now to return part of these funds to our shareholders if we don’t find the targets” fitting Axa’s strategy.
Axa last year generated about 14 percent of group revenues from the U.S. The insurer made 905 million euros in operating profit from life and savings in the country last year, an 8.5 percent increase from a year earlier. About a quarter of its life and savings new business is generated in the U.S., where it is the third-largest provider of variable annuities and the largest insurer in the retirement business segment.
Citigroup Inc. said in a note that a back-of-the-envelope calculation suggests an IPO of Axa’s U.S. life business could potentially raise between 3 billion euros and 4 billion euros, assuming that half is sold at a 20 percent discount.
“We have seen over the last month some regulatory divergence between Europe and the U.S.,” Buberl said on a call with journalists. The IPO will allow Axa’s U.S. activities to better compete with its U.S. rivals as economic recovery and the new administration may favor “stronger and more profitable growth” conditions.
The firm plans to convert about $1 billion of outstanding debt owed by the U.S. unit to the group into equity ahead of the IPO.
©2017 Bloomberg L.P.